Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I. (Q33222417)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

24 July 2017

Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I. (English)

1 reference

Europe PubMed Central

24 July 2017

object named as

Baohai Shao

1

0 references

5

object named as

Koji Uchida

1 reference

Europe PubMed Central

24 July 2017

author name string

Xiaoyun Fu

2

1 reference

Europe PubMed Central

24 July 2017

Thomas O McDonald

3

1 reference

Europe PubMed Central

24 July 2017

Pattie S Green

4

1 reference

Europe PubMed Central

24 July 2017

Kevin D O'Brien

6

1 reference

Europe PubMed Central

24 July 2017

John F Oram

7

1 reference

Europe PubMed Central

24 July 2017

Jay W Heinecke

8

1 reference

Europe PubMed Central

24 July 2017

language of work or name

0 references

publication date

25 August 2005

1 reference

Europe PubMed Central

24 July 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

24 July 2017

280

1 reference

Europe PubMed Central

24 July 2017

43

1 reference

Europe PubMed Central

24 July 2017

36386-36396

1 reference

Europe PubMed Central

24 July 2017

Protein oxidation and aging

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Biological interactions of alpha,beta-unsaturated aldehydes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Protein-bound acrolein: potential markers for oxidative stress

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsatu

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Current status of acrolein as a lipid peroxidation product

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Role of oxidized low density lipoprotein in atherogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

N(epsilon)-(3-methylpyridinium)lysine, a major antigenic adduct generated in acrolein-modified protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Immunochemical crossreactivity of antibodies specific for "advanced glycation endproducts" with "advanced lipoxidation endproducts".

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

High-density lipoprotein--the clinical implications of recent studies

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Tangier disease as a test of the reverse cholesterol transport hypothesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

New insights into the regulation of HDL metabolism and reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Lysine residues direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Inhibition of lecithin-cholesterol acyltransferase and modification of HDL apolipoproteins by aldehydes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Regulation and Mechanisms of ATP-Binding Cassette Transporter A1-Mediated Cellular Cholesterol Efflux

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Acrolein modifies apolipoprotein A-I in the human artery wall

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Cell proliferation in human coronary arteries

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

The effects of altered apolipoprotein A-I structure on plasma HDL concentration

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Apolipoprotein structural organization in high density lipoproteins: belts, bundles, hinges and hairpins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

The role of apolipoprotein A-I helix 10 in apolipoprotein-mediated cholesterol efflux via the ATP-binding cassette transporter ABCA1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Identification of an apolipoprotein A-I structural element that mediates cellular cholesterol efflux and stabilizes ATP binding cassette transporter A1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Presence of hypochlorite-modified proteins in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Structural models of human apolipoprotein A-I.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Identifiers

10.1074/JBC.M508169200

1 reference

Europe PubMed Central

24 July 2017

1 reference

Europe PubMed Central

24 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33222417&oldid=1837297437"